Absci to participate in the h.c. wainwright bioconnect virtual conference

Vancouver, washington, dec. 30, 2021 (globe newswire) -- absci corporation (nasdaq: absi), the drug and target discovery company harnessing deep learning ai and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating in the h.c. wainwright bioconnect virtual conference.
ABSI Ratings Summary
ABSI Quant Ranking